What's new

Human medicines European public assessment report (EPAR): Rilonacept FGK Representative Service GmbH , rilonacept, Status: Application withdrawn

Human medicines European public assessment report (EPAR): Rilonacept FGK Representative Service GmbH , rilonacept, Status: Application withdrawn

Feb 28, 2025 - 13:43
 0
Human medicines European public assessment report (EPAR): Rilonacept FGK Representative Service GmbH , rilonacept, Status: Application withdrawn
Human medicines European public assessment report (EPAR): Rilonacept FGK Representative Service GmbH , rilonacept, Status: Application withdrawn
Read More

Tags:

Previous Article

Withdrawn application: Dupixent, 18/02/2025

Next Article

Withdrawn application: Bimervax, 05/02/2025

Related Posts

EMEA-001716-PIP04-19-M01

EMEA-001716-PIP04-19-M01

Feb 14, 2025  0

Human medicines European public assessment report (EPAR): Hulio, adalimumab, Date of authorisation: 17/09/2018, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 9, 2025  0

Human medicines European public assessment report (EPAR): Rozlytrek, entrectinib, Date of authorisation: 31/07/2020, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 14, 2025  0